CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation ...

VORDEN, Netherlands & SILICON VALLEY, Calif.--(BUSINESS WIRE)--Ridge Security, a leader in autonomous cybersecurity validation and adversarial exposure management, today announced it has been named a ...

With their victory at BLAST Slam VII, Team Yandex now have three Tier 1 tournament titles this season. Eastern European Dota 2 powerhouse Team Yandex have been crowned as champions of BLAST Slam VII ...

Anthropic Tuesday publicly released Claude Fable 5, its first “Mythos-class” model that it says surpasses its previous frontier Opus models in overall capabilities. But the model’s launch today comes ...

Pacific Investment Management Co. is warning that the “credit loss cycle is upon us” as heavy spending on artificial intelligence could widen economic outcomes and hit lower-quality borrowers, ...

Private credit’s very bad month started on March 2, when Blackstone Inc.’s BCRED revealed what was at the time its largest investor redemptions ever. It was bookended on April 2, when Blue Owl Capital ...

Best AI-Native Loan Origination Platforms in 2026. Loan origination is being rebuilt around AI. I'm the founder of SecureLend ...

Federal regulators have expanded a civil case involving the alleged loss of $91 million from the Jackson Area Federal Credit Union. Former CEO Leigh Bridges allegedly used credit union money to buy ...

Robin reacts to another big performance from Caitlin Clark. Pitt allegedly rejected Jolie reconciliation as twins near name change Utah canyon BASE jump kills 2, including extreme athlete Andy Lewis ...

In a 32-week extension of its phase 2b VESPER-1 study, patients with obesity or overweight who escalated from placebo to a 2.4 mg weekly dose of berobenatide achieved a non-placebo-adjusted weight ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established ...